Diffuse growth pattern affects E-cadherin expression in invasive breast cancer

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2237-2242

  Brinck, Ulrich ^a   Jacobs, Susanne ^b   Neuss, Michael ^b   Tory, Kalman ^b   Rath, Werner ^b   Kulle, Bettina ^a   Füzesi, Laszlo ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Adhesion molecule; Breast cancer; E cadherin; Growth pattern

Indexed keywords

CELL ADHESION MOLECULE; DNA; UVOMORULIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL ADHESION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CELL DIVISION; EXONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA;

EID: 4444254417     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996.
2. Grunwald GB: The structural and functional analysis of cadherin calcium dependent cell adhesion molecules. Curr Opin Cell Biol 5: 797-805, 1993.
3. Takeichi M: Cadherin cell adhesion receptors as morphogentic regulator. Science 251: 1451-1455, 1991.
4. Wong AS and Gumbiner BM: Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 161: 1191-1203, 2003.
5. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Höfler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994.
6. Kowalski PJ, Rubin MA and Kleer CG: E-cadherin expresssion in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: R217-222, 2003.
7. Umbas R, Schalken J, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ and Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 52: 5104-5109, 1992.
8. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJF, van de Vijver MJ, Cornelisse C and van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115, 1995.
9. Jones J, Royal J and Walker R: E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma. Brit J Cancer 74: 1237-1241, 1996.
10. Moll R, Mitze M, Frixen UH and Birchmeier W: Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143: 1731-1742, 1993.
11. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA and Isola JJ: Reduced E-cadherin expression is associated with invasivenesss and unfavorable prognosis in breast cancer. Am J Clin Pathol 105: 394-402, 1996.
12. Jacquemier J, Eisinger F, Nogues C, Sun ZZ, Guinebretiere JM, Peyrat JP, Geneix J, Lidereau T, Birnbaum D and Sobol H: Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers. Int J Cancer 83: 45-49, 1999.
13. Heimann R, Lan F, McBride R and Hellman S: Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60: 298-304, 2000.
14. Lipponen P, Saarelainen E, Ji H, Aalltomaa S and Syrjanen K: Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 174: 101-109, 1994.
15. Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE and Graff JR: Aberrant methylation of the estrogen receptor and E-cadherin 5' CPG islands increases with malignant progression in human breast cancer. Cancer Res 60: 4346-4348, 2000.
16. Graff JR, Gabrielson E, Fujii H, Baylin SB and Herman JG: Methylation patterns of the E-cadherin 5' CPG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275: 2727-2732, 2000.
17. Kashiwaba M, Tamura G, Suzuki Y, Maesawa C, Ogasawara S, Sakata K and Satodate R: Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 86: 1054-1059, 1995.
18. Kanai Y, Oda T, Tsuda H, Ochiai A and Hirohashi S: Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 85: 1035-1039, 1994.
19. Sarrio D, Moreno-Bueno G, Hardissson D, Sanchez-Estevez C, Guo M, Herman JG, Gamallo C, Esteller M and Palacios J: Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 106: 208-215, 2003.
20. Palacios J, Sarrio D, Garcia-Macias MC, Bryant B, Sobel ME and Merino MJ: Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol 16: 674-678, 2003.
21. World Health Organization: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs Tumors. Tavassoli FA, Devilee P (eds.). IARC Press, Lyon, 2003, pp9-112
22. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow up. Histopathology 19: 403-410, 1991.
23. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M and Farhing MJ: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112: 46-54, 1997.
24. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M and Abe O: Cadherin cell-adhesion molecules in human epithelial tissue and carcinomas. Cancer Res 49: 2128-2133, 1989.
25. Shimoyama Y and Hirohashi S: Cadherin intercellular adhesion molecule in hepatocellular carcinoma: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 57: 131-135, 1991.
26. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M and Mori T: Expression of immunoreactiv E-cadherin adhesion molecules in human cancers. Am J Pathol 139: 17-23, 1991.
27. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS and Millis RR: Epithelial (E-) and placental(P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250, 1993.
28. Bracke ME, van Roy FM and Marcel MM: The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 213: 123-161, 1996.
29. Bogaert van LJ and Maldague P: Infiltrating lobular carcinoma of the female breast. Deviation from the usual histopathologic appearance. Cancer 45: 979-984, 1980.
30. Berx G, Cleton-Jansen A, Strumane K, Deleeuw W, Nollet F, van Roy F and Cornelisse C: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 181: 1919-1925, 1996.
31. Roylance R, Droufakou S, Gorman P, Gilett C, Hart IR, Hanby A and Tomlinson I: The role of E-cadherin in low-grade ductal breast tumourigenesis. J Pathol 200: 53-58, 2003.